The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study

Introduction: Pidotimod, a synthetic dipeptide molecule with biological and immunological activities, is used to reduce the number of exacerbations or pneumonitis in patients with inflammatory diseases. In the present study, we investigated whether Pidotimod modifies the metabolomic pathways measure...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: D’Amato, Maria, Paris, Debora, Molino, Antonio, Cuomo, Paola, Fulgione, Andrea, Sorrentino, Nunzia, Palomba, Letizia, Maniscalco, Mauro, Motta, Andrea
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785784/
https://ncbi.nlm.nih.gov/pubmed/31632269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars